From: Diversity in randomized clinical trials for peripheral artery disease: a systematic review
Outcome/Covariate | Coefficient | p-value |
---|---|---|
Proportion of Women | ||
 Study year | 0.012 | 0.096 |
 Study location (Europe vs non-Europe) | 0.059 | 0.032 |
 Population type (PAD and CLI vs PAD only) | 0.013 | 0.77 |
 Trial length (years) | 0.0086 | 0.25 |
 Duration of enrollment (months) | 0.0003 | 0.84 |
 Number of study locations | 0.0003 | 0.63 |
Mean Age of Participants | ||
 Study year | 0.187 | 0.46 |
 Study location (Europe vs non-Europe) | -0.647 | 0.55 |
 Population type (PAD and CLI vs PAD only) | 0.193 | 0.90 |
 Trial length (years) | -0.035 | 0.90 |
 Duration of enrollment (months) | -0.042 | 0.29 |
 Number of study locations | 0.013 | 0.57 |